• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

A sutdy for analyzing causative genes for common diseases in urinary tract and male sex organs

Research Project

Project/Area Number 12307034
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKochi Medical School

Principal Investigator

SHUIN Taro  Urology, Kochi Medical School, Professor, 医学部, 教授 (80179019)

Co-Investigator(Kenkyū-buntansha) FUJIOKA Tomoaki  Urology, Iwate University School of Medicine, Professor, 医学部, 教授 (80173409)
TSUKAMOTO Taiji  Urology, Sapporo Medical University, Professor, 医学部, 教授 (50112454)
MIKI Tuneharu  Urology, Kyoto prefectural University of Medicine, Professor, 医学部, 教授 (10243239)
UOSAKA Masahiko  Yokohama City University School of Medicine, Professor, 医学部, 教授 (30106330)
AKAZA Hideyuki  Urology, University of Tsukuba School of Medicine, Professor, 医学専門群, 教授 (70010486)
Project Period (FY) 2000 – 2001
Keywordscommon disease / urinary tract caluculi / BPH / Infantile anomaly in male sex organ / genitourinary cancer / DNA microarray analyses
Research Abstract

there are a many common disease in the genitourinary tract organ. For example, urinary tract calculi (uric acid or, oxalic acid calcium calculi), BHP, the anormalies in infant urinary tract and in male sex organs, the genitourinary tract cancer, and male sterility are such kinds of disease. It is difficult to explain such kinds of diseases as single gene diseases such as recessive or dominant hereditary diseases. These are regarded as multifactor diseases. The causative genes in these diseases are not known yet. It is important for us to accumulate DNA from the organs or blood DNA in such patients. It is also essential to analyze single nucleotide polymorphism (SNP) of candidate gene from accumulated DNA. In the present study we selected some among such kinds of common disease and accumulated DNAs from such patients. We tried to collect the 300 DNAs from the diseases such as BPH, urine tract calculi, genitourinary tract cancer (prostatic cancer, urothelial cancer, kidney cancer, germ cell tumor), We also performed DNA microarray analyses with some study designs for such diseases in order to select candidate gene groups. If causative genes are detected and new idea for the treatment is elucidated in urinary tract calculi, BPH, urinary tract anormalv in infancy and male sex organs, the genitourinary tract cancer, future foundations for the urology are established and further advances for clinical diagnosis and treatment become possible.
Blood DNAs are collected in patients with 150 of kidney cancers, 46 of germ cell tumnrs 273 of prostatic cancers, 276 of tumors in the urinary bladder, 141 of PBH, 129 of urine tract calculi, 28 of hypospadia, 9 of VUR, other 56 diseases, and 37 of normality person. Total number reachs to 1145 in this project. We were able to search some candidate genes in DNA microarray analyses in some study designs. Each members also performed a study with their own study project and got some result.

  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Fujiwara H, Emi M, Shuin T, Ogawa O. et al.: "Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series"J Hum Genet. 47(12). 641-648 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Furihata M, Shuin T et al.: "Frequent phosphorylation at serine 392 in overexpressed p53 orotein due to missense mutation in carcinoma of the urinary tract"J Pathol. 197(1). 82-88 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakanishi, H.Miki T et al.: "Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in urostate cancer in vivo"Gene Ther. 10. 434-442 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mizutani Y, Miki T et al.: "Significance of dihydropyrimidine dehydrogenase activity in bladder cancer"Eur. J. Cancer. 37. 569-575 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura E, Ogawa O et al.: "Genetic polymorphisms of theinterleukin-4 receptor alpha gene are associated with an increasing risk and a poorprognosis of sporadic renal cell carcinoma in a Japanese"Chin Cancer Res. 8. 2620-2625 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Habuchi T, Ogawa 0 et al.: "Increased risk ofprostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect"Cancer Res. 60. 5710-5713 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kurashige, T.Tsushima, T., Kumon, H et al.: "NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade"Cancer Res. 60. 5710-5713 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi T, .Kagawa H et al.: "Gene expression profiling of clear cell renal cell carcinom: Gene identification and prognostic classification"Proc Natl Acad Sci USA. 14;98(17). 4671-4674 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kondo K, Hosaka M et al.: "Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological"Genes Chromosomes Cancer. 34(1). 58-68 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yao M, Yoshida M: "VHL alterations associated with good prognosis in sporadic clear-cell renal carcinoma"J Natl Cancer Inst. 94(20). 1569-1575 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yasui T, Kohri K, et al.: "Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model"Nephron. 87. 170-176 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yasui T, Kohri K et al.: "Effects of eicosapentaenoic acid on urinary cicium excretion in calcium stone formers"Euoropean. 39. 580-585 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tada Y, Naito S et al.: "MDR1 Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment"Cli Cancer Res. 6. 4618-4627 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fujiwara H, Emi M, Shuin T, Ogawa O et al.: "Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series"J. Hum Genet. 47(12). 641-8 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Furihata M, Shuin T et al.: "Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract"J Pathol. 197(1). 82-8 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakanishi H, Miki T et al.: "Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo"Gene Ther. 10. 434-442 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani Y, Miki T et al.: "Significance of dihydropyrimidine dehydrogenase activity in bladder cancer"Eur J Cancer. 37. 569-575 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura E, Ogawa O, et al.: "Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population"Clin Cancer Res. 8. 2620-2625 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Habuchi T, Ogawa O, et al.: "Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect"Cancer Res. 60. 5710-5713 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kurashige T, Tsushima T, Kumon H, et al.: "NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma : Correlation with tumor grade"Cancer Res. 61(12). 4671-4674 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi T, Kagawa H, et al.: "Gene expression profiliing of clear cell renal cell carcinoma : Gene identification and prognostic classification"Proc. Natl. acad. Sci. USA. 14 ; 98(17). 9754-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kondo K, Hosaka M, et al.: "Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma : relationship to clinicopathological parameters"Genes Chromosome Cancer. 34(1). 58-68 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yao M, Yoshida M, et al.: "VHL alterations associated with good prognosis in sporadic clear-cell renal carcinoma"J Natl Cancer Inst.. 94(20). 1569-75 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yasui T, Kouri K, et al.: "Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model"Nephron. 87. 170-176 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yasui TT, Kohri K, et al.: "Effects of eicosapentaenoic acid on urinary eleium excretion in calcium stone formers"European Urology. 39. 580-585 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tada Y, Naito S, et al.: "MDRI Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment"Cli Cancer Res.. 6. 4618-4627 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi